HAVCR1 and chronic kidney disease: That both α1m and KIM-1 provided information on risk of ESKD independent of one another demonstrates that quantification of both tubule injury and dysfunction may be complementary for discerning ESKD risk in individuals with diabetes and CKD, highlighting key pathways of kidney disease progression.46